JOSEPH JANKOVIC to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.139
-
New and emerging medical therapies in Parkinson's disease. Expert Opin Pharmacother. 2016; 17(7):895-909.
Score: 0.122
-
The impact of depressive symptoms in early Parkinson disease. Neurology. 2007 Jul 24; 69(4):342-7.
Score: 0.017